Overview

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether treating HSV-2 with either valacyclovir or acyclovir is more effective in suppressing HIV-1 virus levels in people co-infected with HIV-1 and HSV-2.

Phase:

Phase 4

Details

Lead Sponsor:

University of Washington

Treatments:

Acyclovir
Valacyclovir